Current research to overcome T-cell dysfunction in CLL and improve therapies
iwNHL 2016: Highlights from Day 1
Catherine Bollard et al.
Panel discussion on immune therapies for lymphoma - CAR T-cell therapy and the question of cure
Anas Younes et al.
Remission of multiple myeloma with CAR T-cell therapy
Efficacy and safety of CD19-targeted CAR T-cells for relapsed/refractory ALL